National Cancer Institute; Notice of Charter Renewal, 22552 [2017-09794]
Download as PDF
<![CDATA[
22552
Federal Register / Vol. 82, No. 93 / Tuesday, May 16, 2017 / Notices
pain, chronic pain and chronic pain
management, and disparities in pain
and pain care will provide a framework
for development of the strategy upon
which important cross-cutting elements
will be addressed.
Meeting Location: William H. Natcher
Conference Center, Auditorium,
National Institutes of Health, Bethesda,
MD 20892.
Webcast Live: https://
videocast.nih.gov/.
Contact Person: Linda L. Porter,
Ph.D., Director, Office of Pain Policy,
Officer of the Director, National Institute
of Neurological Disorders and Stroke,
NIH, 31 Center Drive, Room 8A31,
Bethesda, MD 20892, Phone: (301) 451–
4460, Email: Linda.Porter@nih.gov.
The meeting is open to the public and
is free. More information can be found
at https://iprcc.nih.gov/.
Individuals who participate in person
or by videocast and who need special
assistance, such as captioning of the call
or other reasonable accommodations,
should submit a request to the Contact
Person listed on this notice at least
seven days prior to the meeting.
Information about the IPRCC and the
Federal Pain Research Strategy is
available on the Web site at https://
iprcc.nih.gov/.
Dated: May 3, 2017.
Walter J. Koroshetz,
Director, National Institute of Neurological
Disorders and Stroke, National Institutes of
Health.
[FR Doc. 2017–09860 Filed 5–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
National Cancer Institute; Notice of
Charter Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the Frederick
National Laboratory Advisory
Committee to the National Cancer
Institute (FNLAC) was renewed for an
additional two-year period on March 30,
2017.
It is determined that the FNLAC is in
the public interest in connection with
the performance of duties imposed on
the Department of Health and Human
Services by law, and that these duties
can best be performed through the
advice and counsel of this group.
Inquiries may be directed to Jennifer
Spaeth, Director, Office of Federal
Advisory Committee Policy, Office of
VerDate Sep<11>2014
16:42 May 15, 2017
Jkt 241001
the Director, National Institutes of
Health, 6701 Democracy Boulevard,
Suite 1000, Bethesda, Maryland 20892
(Mail code 4875), Telephone (301) 496–
2123, or spaethj@od.nih.gov.
Dated: May 10, 2017.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–09794 Filed 5–15–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Clinical Oncology Study Section.
Date: June 12, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton La Jolla Hotel, 3299
Holiday Court, La Jolla, CA 92037.
Contact Person: Malaya Chatterjee, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6192,
MSC 7804, Bethesda, MD 20892, 301–806–
2515, chatterm@csr.nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Language and Communication Study
Section.
Date: June 12–13, 2017.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Wind Cowles, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
Bethesda, MD 20892, 301–437–7872,
cowleshw@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
Group; Aging Systems and Geriatrics Study
Section.
Date: June 12–13, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Inese Z. Beitins, M.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7892, Bethesda, MD 20892, 301–435–
1034, beitinsi@csr.nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Community-Level Health Promotion Study
Section.
Date: June 12–13, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road NW.,
Washington, DC 20008.
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 3166, Bethesda, MD 20892, 301–
451–8428, wup4@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Basic Mechanisms of Cancer
Therapeutics Study Section.
Date: June 12–13, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz-Carlton Hotel, 1700 Tysons
Boulevard, McLean, VA 22102.
Contact Person: Lambratu Rahman Sesay,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6214,
MSC 7804, Bethesda, MD 20892, 301–451–
3493, rahman-sesayl@csr.nih.gov.
Name of Committee: Oncology 1—Basic
Translational Integrated Review Group;
Cancer Genetics Study Section.
Date: June 12–13, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Juraj Bies, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4158, MSC 7806, Bethesda, MD
20892, 301–435–1256, biesj@mail.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Drug Discovery and Molecular
Pharmacology Study Section.
Date: June 12–13, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Dupont Circle Hotel, 1500 New
Hampshire Avenue NW., Washington, DC
20036.
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 82, Number 93 (Tuesday, May 16, 2017)]
[Notices]
[Page 22552]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-09794]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Charter Renewal
In accordance with Title 41 of the U.S. Code of Federal
Regulations, Section 102-3.65(a), notice is hereby given that the
Charter for the Frederick National Laboratory Advisory Committee to the
National Cancer Institute (FNLAC) was renewed for an additional two-
year period on March 30, 2017.
It is determined that the FNLAC is in the public interest in
connection with the performance of duties imposed on the Department of
Health and Human Services by law, and that these duties can best be
performed through the advice and counsel of this group.
Inquiries may be directed to Jennifer Spaeth, Director, Office of
Federal Advisory Committee Policy, Office of the Director, National
Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda,
Maryland 20892 (Mail code 4875), Telephone (301) 496-2123, or
spaethj@od.nih.gov.
Dated: May 10, 2017.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-09794 Filed 5-15-17; 8:45 am]
BILLING CODE 4140-01-P
